Distinct Nasal Microbiome Profiles and Prediction Model for Allergic Rhinitis, Nonallergic Rhinitis, and Healthy Children Authors: Kantima Kanchanapoomi, Iyarit Thaipisuttikul, Perapon Nitayanon, Witchaya Srisuwatchari, Punchama Pacharn, Nualanong Visitsunthorn, Orathai Jirapongsananuruk Published: 2025 ABSTRACT ABSTRACTObjectivesAdult studies reported differences in nasal microbiota composition among patients with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls (HCs), whereas pediatric data remain limited. This study compared the nasal microbiomes of children with AR, NAR, and HC, investigated factors influencing these microbiomes, and developed a predictive model to differentiate these conditions based on microbiome data.MethodsNasal swab samples were collected from children with AR, NAR, and HC. Microbial characterization was performed using 16S rDNA sequencing to analyze bacterial composition. Relevant demographic data and influencing factors were collected.ResultsSixty participants (median age 6.3 [4.3–8.4] years, 51.6% males) were categorized into AR (n = 24), NAR (n = 14), and HC (n = 22). Significant differences in alpha and beta diversity were observed among groups (p < 0.01 and p < 0.05, respectively). The AR and NAR groups exhibited lower Pielou's evenness than HC (FDR‐adjusted p < 0.01 and p = 0.02, respectively). Compared to HC, the AR group showed a higher abundance of Escherichia‐Shigella, Negativicoccus, and Campylobacter. In contrast, Dolosigranulum was enriched while the Enterobacteriaceae family was depleted in the NAR group. Household pets and breastfeeding duration significantly influenced nasal microbiome diversity regardless of the disease groups. A prediction model of nasal microbial distribution for AR, NAR, and HC identified 14 taxa critical for distinguishing these groups (accuracy of 0.83).ConclusionThis pilot study identified preliminary differences in nasal microbiome diversity and composition among children with AR, NAR, and HC. Differential microbial abundances may reflect distinct rhinitis phenotypes. However, these findings are hypothesis‐generating and require validation in larger, independent cohorts. Introduction Rhinitis is the persistent inflammation of the nasal mucosa, causing symptoms like rhinorrhea, congestion, sneezing, and itching. Symptom presentation varies with the type of rhinitis. Symptoms lasting over an hour daily for at least two consecutive days help diagnose rhinitis [1]. If symptoms persist for over 12 weeks, chronic rhinitis is diagnosed and classified as allergic rhinitis (AR) or nonallergic rhinitis (NAR) [2]. AR diagnosis requires chronic rhinitis symptoms and evidence of an IgE‐mediated response, such as a positive skin prick test (SPT) or serum‐specific IgE (sIgE) to aeroallergens. In contrast, NAR lacks evidence of a systemic IgE‐mediated response, distinguishing it from AR [1]. Multiple factors, including genetic predisposition and environmental exposures, influence AR and NAR development. Recently, the microbiome's role has gained attention. The microbiome comprises bacteria, fungi, viruses, and their genetic material [3]. The respiratory microbiome, including the nasal microbiome, defends against respiratory pathogens and maintains respiratory tract function, potentially impacting rhinitis development [4]. Imbalances in the nasal microbiome may enhance the risk of developing allergic conditions like AR or NAR. A longitudinal study by Ta et al. [5] revealed that the nasal microbiome in children from birth to 18 months of age showed a decrease in microbial diversity among those with early‐onset rhinitis, in contrast to control infants. A previous study showed significant differences in the nasal microbiota composition in patients with AR compared to healthy subjects (aged 8–62 years). For instance, the AR group exhibited an increased abundance of Klebsiella, Escherichia coli, and Staphylococcus aureus [6]. Additionally, a systematic review of the nasal microbiome in children and adolescents with AR found an evident imbalance in the bacterial composition within the nasal mucosa of these patients [7]. In the case of NAR, differences in nasal microbiota composition among adult patients with AR, NAR, and healthy controls (HCs) were explored. A significant increase in the abundance of Vibrio vulnificus and Acinetobacter baumannii was found in AR patients compared to those with NAR. On the other hand, AR patients exhibited a lower abundance of Lactobacillus murinus, Lactobacillus iners, Proteobacteria, Pseudomonadales, and E. coli [8]. These findings highlight the complex microbial variations associated with different rhinitis conditions. Despite evidence of imbalanced microbiota in adults with AR and NAR, comparisons between nasal microbiota in children with AR and NAR remain limited. Findings of distinct microbial profiles in children with AR, NAR, and HCs may guide the development of novel preventive or therapeutic approaches. This study aims to compare the nasal microbiome profiles among children with AR, NAR, and HCs. Additionally, it investigates factors influencing nasal microbiome composition and explores predictive models to differentiate AR, NAR, and HC based on microbiome data. Materials and Methods Study Design and Subjects This cross‐sectional study was conducted at the Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, with approval from the Institutional Review Board. Informed consent was obtained from all participants. Children aged 3–12 years diagnosed with AR or NAR and followed at the pediatric allergy clinic were enrolled. Healthy children from the well‐child clinic were screened by allergists to confirm the absence of chronic rhinitis symptoms and were enrolled as controls [2]. Children with recent respiratory tract infections (within 2 months), nasal or sinus surgery (within 6 months), or chronic respiratory tract infections were excluded. Children with asthma, allergic skin diseases, food allergies, or a history of intranasal corticosteroid use were also excluded. AR was defined by the presence of chronic rhinitis symptoms, including rhinorrhea, congestion, itching, and sneezing, triggered after exposure to allergens. The diagnosis was confirmed by a positive SPT or sIgE to aeroallergens. NAR was defined as chronic rhinitis symptoms without evidence of aeroallergen sensitization. Demographic data were collected from medical records and interviews. Skin Prick Test The SPT was performed using common aeroallergens, including house dust mites (Dermatophagoides pteronyssinus, Dp and Dermatophagoides farinae, Df), American and German cockroaches, cat and dog dander, Acacia, careless weeds, grass pollens (Bermuda and Johnson), and molds (Alternaria spp., Cladosporium spp., Penicillium spp., Aspergillus spp., and Curvularia spp.). Commercial allergens from ALK‐Abello, Port Washington, NY, were used for testing. Histamine (10 mg/mL) and glycerine were used as positive and negative controls, respectively. A positive SPT result was defined as a mean wheal diameter at least 3 mm greater than the negative control for at least one aeroallergen. Participants were instructed to discontinue antihistamines at least 7 days before testing. Sample Collection Nasal swabs were collected 1–1.5 cm from the nostril using a specialized cotton swab (BD BBL CultureSwab EZII, Brescia, Italy) as suggested by a previous report [9]. Five rotations were performed on each side to ensure comprehensive sampling of the nasal cavity. The swabs were placed in sterile containers and stored at 4°C. Subsequently, the swabs were transferred to −80°C storage until DNA extraction. 16S rDNA Sequencing Analysis Genomic DNA was extracted from the swab samples using the QIAamp PowerFecal Pro Kit (QIAGEN, Germany), following the manufacturer's instructions. The genomic DNA was purified and submitted for V3–V4 16S amplicon paired‐end sequencing on the Illumina MiSeq platform (GENEWIZ, Suzhou, China). The raw sequences were analyzed using the Quantitative Insights Into Microbial Ecology 2 (QIIME 2) 2023.5 pipeline, a tool for microbial ecology analysis [10]. Sequence quality control was performed with the q2‐demux plugin, followed by denoising using DADA2 to generate amplicon sequence variant (ASV) frequencies [11]. ASVs were aligned with Multiple sequence Alignment based on Fast Fourier Transform (MAFFT), and a phylogenetic tree was constructed with FastTree 2 [12, 13]. Alpha diversity metrics (observed features, Chao1 index, Abundance‐based Coverage Estimator (ACE) metric, Faith's phylogenetic diversity, Shannon's index, Gini–Simpson's index, and Pielou's evenness) were calculated using the q2‐diversity plugin. Beta‐diversity metrics (Jaccard distance, Bray‐Curtis dissimilarity, weighted UniFrac, and unweighted UniFrac) were also calculated at a sequencing depth of 37,983 sequences per sample [14, 15, 16]. Taxonomy was assigned to ASVs using QIIME 2's classify‐sklearn naive Bayes taxonomy classifier with the SILVA 138.1 99% database [17, 18]. Differential abundances were determined using the Analysis of Compositions of Microbiomes with the Bias Correction (ANCOM‐BC) method [19]. A prediction model based on nasal microbial composition was built using the q2‐sample‐classifier plugin, which utilizes a supervised learning classifier. Twenty percent of the data was set aside for testing the prediction model. A random forest classifier was trained with the rest of the data under fivefold cross‐validation without hyperparameter tuning or feature elimination [20]. Statistical Analysis All statistical analyses of demographic data were performed using SPSS Statistics version 22 software (SPSS Inc., Chicago, IL, USA). Subject characteristics were analyzed using descriptive statistics, including frequencies, percentages, medians, and interquartile range (IQR). Chi‐squared tests were used to compare data among the AR, NAR, and HC groups. Quantitative data, such as age and number of children in the house, were analyzed using the Kruskal–Wallis test for comparisons among the three groups. The significance level was set at p ≤ 0.05. Statistical significance for alpha diversity was tested using the Kruskal–Wallis test; p values shown were FDR‐adjusted, while beta diversity was assessed using PERMANOVA and PERMDISP tests with 999 permutations. Results Demographic Data and Environmental Factors Influenced the Change in the Nasal Microbiome The study recruited 60 children: 24 diagnosed with AR, 14 with NAR, and 22 HC. Demographic data and environmental factors are summarized in Table 1. The median age was 6.3 (4.5, 8.4) years, and 51.6% of children were male. In the AR group, the most common sensitized aeroallergen was house dust mites (87.5%; Dp 75.0%, Df 83.3%), followed by cockroaches (29.2%; American cockroach 25.0%, German cockroach 16.7%), cat (20.8%), Bermuda grass (16.7%), Johnson grass (8.3%), acacia (8.3%), careless weed (8.3%), and dog (4.2%). None of the participants were sensitized to molds. Table 1Demographic data of children in allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy control (HC) groups.CharacteristicsTotal (n = 60)AR (n = 24)NAR (n = 14)HC (n = 22) p valueMale, n (%)31 (51.6)12 (50.0)8 (57.1)11 (50.0)0.90Age, years, M (Q 1, Q 3)6.3 (4.3, 8.4)6.6 (4.6, 8.5)6.1 (4.8, 7.3)6.5 (3.9, 9.0)0.42Family history of atopy, n (%)36 (60.0)18 (75.0)9 (64.3)9 (40.9)0.06Birth route, n (%)0.98Vagina33 (55.0)13 (54.5)8 (57.1)12 (54.5)Cesarean section27 (45.0)11 (45.8)6 (42.9)10 (45.5)Number of children in the house, M (Q 1, Q 3)2.0 (1.0, 2.0)2.0 (1.0, 2.0)1.0 (1.0, 2.0)2.0 (1.0, 3.25)0.15Daytime care, n (%)1.00Home3 (5.0)1 (4.2)1 (7.1)1 (4.5)Nursery/kindergarten31 (51.7)13 (54.2)7 (50.0)11 (50.0)School26 (43.3)10 (41.7)6 (42.9)10 (45.5)Household pets, n (%)21 (35.0)5 (20.8)7 (50.0)9 (40.9)0.15Duration of breastfeeding, n (%)0.93None4 (6.7)1 (4.2)2 (14.3)1 (4.5)> 0–6 months27 (45.0)11 (45.8)7 (50.0)9 (40.9)7–12 months8 (13.3)4 (16.7)1 (7.1)3 (13.6)13–18 months8 (13.3)2 (8.3)2 (14.3)4 (18.2)19–24 months4 (6.7)1 (4.2)1 (7.1)2 (9.1)> 24 months9 (15.0)5 (20.8)1 (7.1)3 (13.6)Age of formula introduction, n (%)0.68> 0–6 months22 (36.7)9 (37.5)7 (50.0)6 (27.3)7–12 months19 (31.7)6 (25.0)5 (35.7)8 (36.4)13–18 months8 (13.3)4 (16.7)0 (0)4 (18.2)19–24 months1 (1.7)1 (4.2)0 (0)0 (0)> 24 months10 (16.7)4 (16.7)2 (14.3)4 (18.2)Age of start solid food, n (%)0.58< 4 months3 (5.0)0 (0)1 (7.1)2 (9.1)4–6 months34 (56.7)14 (58.3)9 (64.3)11 (50.0)> 6 months23 (38.3)10 (41.7)4 (28.6)9 (40.9)Type of solid food, n (%)0.09Homemade food52 (86.7)23 (95.8)10 (71.4)19 (86.4)Commercial food8 (13.3)1 (4.2)4 (28.6)3 (13.6)Antibiotic use in 3 months before recruitment, n (%)21 (35.0)7 (29.2)9 (64.3)5 (22.7)0.03a Frequency of antibiotic use in 3 months before recruitment, n (%)0.04 a None39 (65.0)17 (70.8)5 (35.7)17 (77.3)1 time18 (30.0)5 (20.8)8 (57.1)5 (22.7)2 times2 (3.3)2 (8.3)0 (0)0 (0)> 3 times1 (1.7)0 (0)1 (7.1)0 (0)Antibiotic use in 12 months before recruitment, n (%)46 (78.0)17 (70.8)11 (84.6)18 (81.8)0.56Frequency of antibiotic use in 12 months before recruitment, n (%)0.82None13 (21.7)7 (29.2)2 (14.3)4 (18.2)1–3 times40 (66.7)15 (62.5)10 (71.4)15 (68.2)4–6 times7 (11.7)2 (8.3)2 (14.3)3 (13.6)URI in 12 months before recruitment, n (%)47 (78.3)19 (79.2)10 (71.4)48 (81.8)0.79URI in 12 months before recruitment, n (%)0.69None13 (21.7)5 (20.8)4 (28.6)4 (18.2)1–3 times33 (55.0)15 (62.5)6 (42.9)12 (54.5)4–6 times12 (20.0)3 (12.5)3 (21.4)6 (27.3)Abbreviations: URI, upper respiratory tract infection. a p < 0.05.John Wiley & Sons, Ltd. Demographic data of children in allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy control (HC) groups. Abbreviations: URI, upper respiratory tract infection. p < 0.05. A family history of atopy was reported in 60% of all children, with a lower prevalence in the HC group. No significant differences were observed among the three groups regarding sex, age, family history of atopy, or birth route. Similarly, environmental factors, including the number of children in the household, daytime care, and household pets, did not differ significantly among the groups. Only 4 participants (6.7%) were not breastfed, while 48.3% were breastfed for more than 6 months. Most children (68.4%) began infant formula feeding before 12 months of age. No significant differences were observed among the three groups in breastfeeding duration (p = 0.93) or in the age at which infant formula was introduced (p = 0.68). Most children (56.7%) started solid foods between 4 and 6 months of age and predominantly consumed homemade food (86.7%). However, no significant differences were observed among the AR, NAR, and HC (p = 0.58 and p = 0.09, respectively). The proportion of children who used antibiotics and the frequency of antibiotic use in the 3 months before recruitment was significantly higher in the NAR group compared to the other groups (p = 0.03 and p = 0.04, respectively). However, the proportion of children who used antibiotics and the frequency of antibiotic use in the 12 months before recruitment was not significantly different among the three groups (p = 0.56 and p = 0.82, respectively). Additionally, the proportion of children with upper respiratory tract infections (URIs) and the frequency of URIs in the 12 months before recruitment were not significantly different among the three groups (p = 0.79 and p = 0.69, respectively). None of the participants used prebiotics or probiotics. Characteristics of the Nasal Microbiome Using 16S rDNA‐based sequencing, we retrieved 3,083,736 high‐quality sequence reads from nasal mucosa samples, with a median of 48,942 sequence reads per sample (44,214.75–58,921.75). A total of 217 ASVs were identified from these sequences. Among these features, four core genera were present in 80% of the samples: Corynebacterium, Staphylococcus, Cutibacterium, and Streptococcus. The composition of nasal bacterial communities varied among children with AR, NAR, and HC (Figure 1A,B). Notably, Corynebacterium was the most prevalent bacterial genus across all groups, followed by Staphylococcus (Figure 1B). Furthermore, the average relative abundance of Moraxella was higher in both the AR and NAR groups compared with HC. In contrast, Haemophilus and Dolosigranulum were predominantly found in children with NAR only. The relative abundance of the nasal microbiome among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls shown at the phylum (A) and genus levels (B). Comparisons of Nasal Microbial Diversity Among AR, NAR, and HC Groups The alpha diversity analysis revealed significant distinctions among children with AR, NAR, and HC across Pielou's evenness, Shannon index, and Gini–Simpson's index (p < 0.01 for all indices). Notably, both the AR and NAR groups exhibited significantly lower diversity in Pielou's evenness compared to HC (FDR‐adjusted p < 0.01 and 0.02, respectively). Moreover, the AR group displayed significantly reduced diversity in both the Shannon and Gini–Simpson indices compared to HC (FDR‐adjusted p < 0.01 and 0.02, respectively). There was no statistically significant difference in alpha diversity between the AR and NAR groups (Figure 2A). None of the other alpha diversity indices showed significant differences among groups (Supporting Information S1: Figure 1). Comparisons of nasal microbial diversity among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls. (A) Alpha diversity, assessed using Pielou's evenness, Shannon index, and Gini–Simpson's index analyses. (B) Beta diversity, assessed using Bray–Curtis, Jaccard, unweighted UniFrac, and weighted UniFrac analyses. a p < 0.05. The beta‐diversity analysis revealed significant differences in microbial diversity among the AR, NAR, and HC groups (PERMANOVA with 999 permutations, p < 0.01 for all distance metrics). The principal coordinate analysis (PCoA) plots of each distance metric are shown in Figure 2B. Pairwise PERMANOVA confirmed the significant differences in AR versus NAR across all metrics, and HC versus NAR groups across all metrics except Weighted UniFrac (Table 2). However, significant differences in dispersion were detected in AR versus NAR for Jaccard distance and weighted UniFrac, and in HC versus NAR for Jaccard distance (PERMDISP, 999 permutations, p < 0.05), suggesting that the beta‐diversity difference of these pairs may be confounded by dispersion effects (Supporting Information S3: Tables 1 and 2). Interpretation of these comparison pairs should be done cautiously. Nonetheless, the overall trend suggested significant differences in microbial composition among groups (Figure 2B). On the other hand, AR versus HC were significant only in Jaccard distance and unweighted UniFrac metrics. Table 2FDR‐adjusted p value of pairwise analyses between groups (PERMANOVA, 999 permutations).PERMANOVAFDR‐adjusted p valueAR vs. HCAR vs. NARHC vs. NARBray–Curtis dissimilarity0.140.003a 0.005 a Jaccard distance0.01 a 0.003 a , b 0.003 a , b Unweighted UniFrac0.02 a 0.003 a 0.003 a Weighted UniFrac0.140.003 a , b 0.07Number of permutations999999999Abbreviations: AR, allergic rhinitis; HC, healthy control; NAR, nonallergic rhinitis. a p < 0.05. b Indicates pairwise analyses with significant differences in dispersion (PERMDISP, 999 permutations).John Wiley & Sons, Ltd. FDR‐adjusted p value of pairwise analyses between groups (PERMANOVA, 999 permutations). Abbreviations: AR, allergic rhinitis; HC, healthy control; NAR, nonallergic rhinitis. p < 0.05. Indicates pairwise analyses with significant differences in dispersion (PERMDISP, 999 permutations). The Differential Abundances of the Nasal Microbiome From AR and NAR Compared to the HC Group Among the genera, the AR group exhibited a significant increase in Escherichia‐Shigella, Negativicoccus, and Campylobacter, compared to the HC group (Figure 3A). In contrast, the NAR group displayed a distinct pattern, with Dolosigranulum as the most enriched genus compared to the HC group. Other enriched genera included Neisseria, Actinobacillus, Streptococcus, Gemella, Bergeyella, and Rothia. Conversely, the Enterobacteriaceae family exhibited the most significant depletion in the NAR group compared to the HC group (Figure 3B). Additional depleted genera included Lawsonella, Anaerococcus, Peptoniphilus, and Ralstonia. The differential abundance of the dominant nasal microbiome in children with allergic rhinitis (AR, A) and nonallergic rhinitis (NAR, B), compared to healthy controls. Factors Associated With Variations in the Diversity of the Main Nasal Microbiome Alpha diversity was analyzed to assess its variation in relation to patients' health‐related factors. These factors included demographics (e.g., sex, age, family history of atopy, birth route, and place of daytime care), household characteristics (e.g., number of children, household pets), feeding practices (e.g., breastfeeding duration, age of formula introduction, and age of starting and type of solid food), and medical history (e.g., antibiotic use in 3 months and the number of antibiotic use in the past 3 and 12 months, URI and the number of URI in the past 12 months). Significant differences in nasal microbiome diversity were observed in relation to household pet ownership and breastfeeding duration, regardless of disease groups (Figure 4 and Supporting Information S2: Figure 2). Other factors did not show significant effects. The effect of antibiotic use in 3 months and the number of antibiotic use in the past 3 and 12 months are shown in Supporting Information S3: Table 3. Box plots of alpha diversity in the nasal microbiome illustrating factors influencing diversity: (A) the influence of household pets, assessed using Pielou's evenness and Shannon index analyses. (B) The impact of breastfeeding during the first 6 months, evaluated using Chao1, observed features, Shannon index, Abundance‐based Coverage Estimator (ACE) metric, and Faith's phylogenetic diversity analyses. Household pet ownership is significantly associated with variations in the diversity of the nasal microbiome. Specifically, both Pielou's evenness and Shannon index analyses showed significantly lower nasal microbiome diversity in households with pets (FDR‐adjusted p = 0.05 and p = 0.03, respectively) as shown in Figure 4A. Breastfeeding during the first 6 months of life was another factor associated with the nasal microbiome. Breastfed children exhibited significantly higher nasal microbiome diversity, as indicated by Chao1, observed features, Shannon index, ACE, and Faith's phylogenetic analyses (FDR‐adjusted p = 0.04, p = 0.04, p = 0.03, p = 0.04, and p = 0.05, respectively) as shown in Figure 4B. A Prediction Model of Nasal Microbial Distribution for AR and NAR A supervised machine learning method using a random forest estimator was employed to classify disease groups in the test set. The model demonstrated robust predictive capability in distinguishing among the AR, NAR, and HC groups. Receiver operating characteristic (ROC) curves were used to evaluate model performance. The area under the curve (AUC) values for the AR, NAR, and HC groups were 0.89, 1.00, and 0.97, respectively, with an average AUC of 0.96 (Figure 5A). The model achieved an overall accuracy of 0.83. Interestingly, the sensitivity and specificity of the model for NAR were both 100%. Fourteen taxa were identified as key predictors for distinguishing the AR, NAR, and HC groups. The most significant taxa included Streptococcus, Staphylococcus, and Corynebacterium, followed by Haemophilus and Enterobacteriaceae. Other important taxa included Negativicoccus, Escherichia‐Shigella, Veillonella, Lawsonella, Cutibacterium, Campylobacter, Dolosigranulum, Moraxella, and Gemella (Figure 5B and Table 3). A prediction model leveraging the nasal microbiome to classify allergic rhinitis, nonallergic rhinitis, and healthy controls: (A) receiver operating characteristic (ROC) curves evaluating the model's performance, with the area under the curve (AUC) as the performance metric, and (B) a heatmap displaying the 14 taxa included in the prediction model. Table 3Feature importance of microbial taxa in the prediction model distinguishing allergic rhinitis, nonallergic rhinitis, and healthy controls.Type of bacteriaFeature importanced_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Streptococcaceae;g_Streptococcus0.149118064d_Bacteria;p_Firmicutes;c_Bacilli;o_Staphylococcales;f_Staphylococcaceae;g_Staphylococcus0.116403094d_Bacteria;p_Actinobacteriota;c_Actinobacteria;o_Corynebacteriales;f_Corynebacteriaceae;g_Corynebacterium0.110135823d_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacterales;f_Pasteurellaceae;g_Haemophilus0.084210743d_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacterales;f_Enterobacteriaceae;_0.080747551d_Bacteria;p_Firmicutes;c_Negativicutes;o_Veillonellales‐Selenomonadales;f_Veillonellaceae;g_Negativicoccus0.064549814d_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacterales;f_Enterobacteriaceae;g_Escherichia‐Shigella0.060825088d_Bacteria;p_Firmicutes;c_Negativicutes;o_Veillonellales‐Selenomonadales;f_Veillonellaceae;g_Veillonella0.058983206d_Bacteria;p_Actinobacteriota;c_Actinobacteria;o_Corynebacteriales;f_Corynebacteriaceae;g_Lawsonella0.053221073d_Bacteria;p_Actinobacteriota;c_Actinobacteria;o_Propionibacteriales;f_Propionibacteriaceae;g_Cutibacterium0.052677399d_Bacteria;p_Campylobacterota;c_Campylobacteria;o_Campylobacterales;f_Campylobacteraceae;g_Campylobacter0.051901813d_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Carnobacteriaceae;g_Dolosigranulum0.048573538d_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Pseudomonadales;f_Moraxellaceae;g_Moraxella0.041755985d_Bacteria;p_Firmicutes;c_Bacilli;o_Staphylococcales;f_Gemellaceae;g_Gemella0.02689681John Wiley & Sons, Ltd. Feature importance of microbial taxa in the prediction model distinguishing allergic rhinitis, nonallergic rhinitis, and healthy controls. Discussion Allergic diseases result from genetic predisposition and environmental factors. The microbiome is important in the development of AR, asthma, atopic dermatitis, and food allergy [21]. Considerable research has explored the respiratory microbiota's role in asthma's etiology, severity, and phenotype [22, 23]. The nasal microbiome, as a microbial barrier, may modulate immune responses in chronic rhinitis, warranting investigation into its role in AR and NAR [23, 24]. However, such studies remain limited. To our knowledge, this study is the first to compare nasal microbiomes among children with AR, NAR, and HC. Distinct variations in nasal microbiota diversity and composition were observed among the three groups. Moraxella predominated in children with AR; while Haemophilus, and Dolosigranulum alongside Moraxella, were dominant in NAR (Figure 1B). Preexisting nasal dysbiosis may predispose individuals to NAR. Children with NAR had a higher proportion of sinusitis, the most common comorbidity associated with NAR in children [25]. NAR may promote Haemophilus and Moraxella colonization, increasing sinusitis susceptibility. Frequent sinusitis may, in turn, drive colonization by these organisms. Frequent antibiotic use in the NAR group likely exacerbated nasal dysbiosis, facilitating specific bacterial colonization. Dolosigranulum was abundant in the NAR group and frequently co‐occurred with Moraxella (Figure 1B). Dolosigranulum was reported to be associated with health and pathogen defense, which may play a balancing role in NAR by mediating interactions between non‐pathogenic and pathogenic bacteria [26, 27]. Children with AR and NAR exhibited lower microbial diversity than HC (Figure 2). Shannon diversity and Gini–Simpson's index were lower in AR and NAR children than in HC (Figure 2A). This uneven distribution of nasal microbiota was reflected in the high abundance of specific genera in AR and NAR children (Figure 1B). Beta diversities of AR and NAR children were more clustered, indicating specific microbiota patterns (Figure 2B). In contrast, HC exhibited broader beta diversities, indicating greater variation among individuals. These findings aligned with a Singapore‐based study, which observed significantly lower alpha diversity in the nasal microbiome of children with early‐onset rhinitis compared to HCs [5]. Distinct differences in bacterial composition were reported between children with rhinitis and controls [5]. Escherichia‐Shigella, Negativicoccus, and Campylobacter were dominant in AR compared to controls (Figure 3A). The relationship between nasal microbiota and inflammation is under investigation, with parallel evidence from the gut microbiome. Shen et al. [28] found higher Escherichia‐Shigella levels in the gut microbiota of allergic infants and greater Bifidobacterium abundance in healthy infants. Escherichia‐Shigella and Klebsiella, members of the Proteobacteria, are associated with gut inflammation, suggesting similar mechanisms in the nasal microbiota [29]. Bifidobacteria, linked to immune balance and reduced allergy risk, may decrease with rising Escherichia‐Shigella levels [29]. Gut dysbiosis may predispose children to allergic diseases, with comparable mechanisms likely in the nasal microbiota. The roles of other genera, such as Negativicoccus and Campylobacter, in AR are not well studied. These genera are associated with gut dysbiosis and may influence allergic pathways through gut–immune interactions. In the NAR group, several genera, including Dolosigranulum, Neisseria, Actinobacillus, Streptococcus, Gemella, Bergeyella, and Rothia, were enriched compared to HC. Conversely, the Enterobacteriaceae family, Lawsonella, Anaerococcus, Peptoniphilus, and Ralstonia, were depleted (Figure 3B). Most of these bacteria, apart from Enterobacteriaceae, are nasal commensals associated with respiratory health. The Enterobacteriaceae family is generally low in healthy nasal microbiomes. Its depletion in NAR likely reflects microbial competition or ecological shifts. Altered nasal microbiota may affect immune responses in NAR. Further investigation is needed to understand how these microbiotas maintain nasal homeostasis and drive inflammation in NAR. Studies in adults have shown significant differences in nasal microbiota among AR, NAR, and HC. Che et al. [8] confirmed distinct nasal microbiota patterns in adults with AR, NAR, and controls, finding higher Dolosigranulum abundance in NAR in the same way as our study. AR and NAR patients had lower Actinobacteria and higher Proteobacteria than controls. AR patients had higher V. vulnificus and A. baumannii than NAR patients, along with lower Lactobacillus spp., Proteobacteria, Pseudomonadales, and E. coli [8]. Similarly, Uzunoğlu et al. [30] identified higher Neisseria, Streptococcus, Gemella, and Rothia in the middle meatus of adults with chronic rhinosinusitis (CRS) than controls and lower anaerobes (Lawsonella, Anaerococcus, and Peptoniphilus), consistent with our findings. These data suggested that chronic inflammation in CRS and NAR shared related nasal dysbiosis patterns. Many environmental factors modulate the nasal microbiome. Our study found that household pets and breastfeeding during the first 6 months were associated with variation diversity of children's nasal microbiome. Children with pets had lower nasal microbiome diversity than those without. Although research on pets and the nasal microbiome is limited, their effects on the gut microbiome have been documented. In infants, pets were associated with greater gut microbiota diversity and richness [31]. Conversely, in adults, pet ownership did not significantly affect gut microbial diversity [32, 33]. These findings suggested that age and developmental stage shaped microbiota responses to environmental factors. Studies also showed shifts in gut microbiota composition with pet ownership, potentially affecting immune responses [32, 33, 34, 35]. Our study found that breastfeeding influenced nasal microbiome diversity. Children breastfed during the first 6 months of life had higher nasal microbiota diversity than those who were not breastfed. Rosas‐Salazar et al. [36] found that exclusively breastfed infants had the lowest alpha diversity in the upper respiratory tract and gut microbiota. The effect was stronger in the gut microbiota and weaker with combined breastfeeding and formula feeding. This discrepancy may be due to differences in age groups. We examined preschool‐ and school‐age children, whereas Rosas‐Salazar's study focused on infants. We did not assess the dose or combination of formula and breastfeeding, limiting direct comparisons. Our dataset included only four children who were not breastfed, which may have influenced the observed differences. These limitations highlight the need for larger, more diverse datasets to explore the relationship between breastfeeding and nasal microbiome diversity. Antibiotic exposure is another potential confounding factor that may influence nasal microbiome composition [4]. In this study, antibiotic use was included as a variable to assess its association with microbial diversity (Supporting Information S3: Table 3). No significant differences in overall alpha diversity were observed in relation to antibiotic use within the previous 3 months or to the number of antibiotic courses during the past 3 and 12 months. However, the NAR group exhibited a higher proportion of recent antibiotic exposure, which may have partially contributed to the observed variation in microbial compositions. Therefore, these findings should be interpreted with caution, as the potential effects of antibiotic exposure cannot be fully excluded given the cross‐sectional design and limited sample size. We examined whether nasal microbial composition could predict clinical conditions. The supervised machine learning model achieved an overall accuracy of 0.83 and an AUC of 0.96. The sensitivity and specificity for NAR were 100%, likely due to the unique nasal microbiota in the NAR group. In an adult study, a random forest model using five bacterial sets achieved AUCs of 0.97 for AR and 0.98 for NAR [8]. These findings suggest that the nasal microbiota may have potential utility as a biomarker for distinguishing between AR, NAR, and HCs. However, the performance of the predictive model, particularly the high metrics in the NAR subgroup, should be interpreted with caution due to the small and unbalanced sample size. Accordingly, the results should be regarded as preliminary and hypothesis‐generating, requiring validation in larger, independent cohorts before any clinical application can be considered. Our study has some limitations. The sample size was small and unevenly distributed across groups, which may have contributed to variability in model performance. Significant differences in dispersion of microbial composition among groups were observed using certain beta‐diversity metrics, and the predictive analyses may contain the risk of bias, given the relatively limited dataset. The imbalance reflects the differing prevalence of AR and NAR, with an approximate AR‐to‐NAR ratio of 3–4:1. Moreover, the cross‐sectional study design precludes establishing causal relationships between nasal microbiome composition and AR or NAR status. Future studies involving larger, more balanced cohorts and comprehensive data on additional factors influencing the nasal microbiome will be essential to further clarify its role in allergic and nonallergic nasal disease. Conclusions In conclusion, this study identifies the nasal microbiome as a key determinant of nasal health, differentiating AR, NAR, and HC children. Significant variations in alpha and beta diversity of the nasal microbiome were observed among the three groups. Differential abundances of dominant nasal microbiota support their use in predictive models for classifying AR, NAR, and HC. These findings may guide strategies to restore a healthy microbiome and support the development of preventive measures and innovative treatments. Author Contributions Kantima Kanchanapoomi: conceptualization, methodology, validation, formal analysis, investigation, data curation, discussion of the results, original draft preparation, review, editing. Iyarit Thaipisuttikul: conceptualization, methodology, software, validation, formal analysis, data curation, drawing conclusion, review, editing. Perapon Nitayanon: software, validation, formal analysis, data curation, review. Witchaya Srisuwatchari: conceptualization, methodology, data collection, discussion and suggestion, review, editing. Punchama Pacharn: conceptualization, methodology, data collection, discussion and suggestion, review, editing. Nualanong Visitsunthorn: methodology, review, editing. Orathai Jirapongsananuruk: conceptual design, methodology, validation, investigation, discussion of the results, original draft preparation, review, editing. Ethics Statement This study was approved by the Institutional Review Board (IRB) of the Faculty of Medicine, Siriraj Hospital, Mahidol University (Approval No. 033/2562, COA No. Si 239/2019). Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supplemental Figure 1: A comparison of alpha diversity among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls, assessed using observed features, Abundance‐based Coverage Estimator (ACE) metric, Chao1 index, and Faith's phylogenetic diversity analyses. Supplemental Figure 2: Box plots illustrating the alpha diversity of the nasal microbiome among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and controls, highlighting the effects of (A) household pets and (B) breastfeeding during the first 6 months. Alpha diversity was assessed using observed features, Chao1 index, Abundance‐based Coverage Estimator (ACE) metric, Faith's phylogenetic, Shannon's index, Gini–Simpson's index, and Pielou's evenness analyses. Supplementary TABLE 1: Results of PERMANOVA and PERMDISP of beta diversity metrics across all groups. Supplementary TABLE 2: Results of pairwise PERMANOVA and PERMDISP of beta diversity metrics between each group. Supplementary TABLE 3: FDR‐adjusted p value of alpha diversity in relation to antibiotic use within the past 3 months, the number of antibiotic courses received in the past 3 and 12 months among allergic rhinitis, nonallergic rhinitis, and healthy controls.